Literature DB >> 26518202

Feasibility of Using Qualitative Interviews to Explore Patients' Treatment Goals: Experience from Dermatology.

Christine Blome1, Kathrin von Usslar2, Matthias Augustin2.   

Abstract

INTRODUCTION: Qualitative interviews are used to assess understandability and content validity of patient-reported outcomes. However, the common approach of asking patients to paraphrase items may not be sufficient to completely reveal item content as understood by patients.
OBJECTIVE: We used qualitative interviews to elicit more detailed information about patients' understanding of treatment goal items for the Patient Benefit Index 2.0 (PBI 2.0). This questionnaire measures patient-relevant benefit from treatments for skin diseases by assessing goal importance prior to and goal attainment after treatment.
METHODS: We interviewed 16 patients with psoriasis, atopic dermatitis, leg ulcers, and vitiligo. Patients were asked to elaborate in detail on their understanding of 15 treatment goal items. Subsequently, they were asked to suggest changes in item wording and to name missing treatment goals. Interview transcripts were analyzed according to an adapted approach of content analysis.
RESULTS: The task was easy for the patients to understand, and they shared detailed information on what each goal meant to them. Results of the content analysis induced a range of revisions of the PBI 2.0 items, including changes in wording (four items) and item order (two items). Four items were deleted because they were found to be redundant or irrelevant, and one item was added to the list of treatment goals.
CONCLUSIONS: Asking patients to elaborate on their item understanding in qualitative interviews provided detailed insight into item content and understandability. This method has helped considerably to improve feasibility and content validity of the PBI 2.0.

Entities:  

Mesh:

Year:  2016        PMID: 26518202     DOI: 10.1007/s40271-015-0149-5

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


  28 in total

Review 1.  Pretesting survey instruments: an overview of cognitive methods.

Authors:  Debbie Collins
Journal:  Qual Life Res       Date:  2003-05       Impact factor: 4.147

2.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

Authors:  Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal:  Value Health       Date:  2011-10-10       Impact factor: 5.725

3.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument.

Authors:  Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal:  Value Health       Date:  2011-10-13       Impact factor: 5.725

4.  Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers.

Authors:  M Augustin; K Herberger; S Hintzen; H Heigel; N Franzke; I Schäfer
Journal:  Br J Dermatol       Date:  2011-10       Impact factor: 9.302

5.  Venous leg ulcer: incidence and prevalence in the elderly.

Authors:  David J Margolis; Warren Bilker; Jill Santanna; Mona Baumgarten
Journal:  J Am Acad Dermatol       Date:  2002-03       Impact factor: 11.527

6.  Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire.

Authors:  M Augustin; A I Gajur; C Reich; S J Rustenbach; I Schaefer
Journal:  Dermatology       Date:  2008-05-02       Impact factor: 5.366

7.  Measurement of patient-relevant benefits in the treatment of chronic hand eczema--a novel approach.

Authors:  Christine Blome; Jürgen Maares; Thomas Diepgen; Stephan Jeffrustenbach; Matthias Augustin
Journal:  Contact Dermatitis       Date:  2009-07       Impact factor: 6.600

8.  Assessing the value of supportive skin care: development and validation of an instrument for evaluating patient-relevant benefit.

Authors:  M Augustin; I Schäfer; S Rabini; C Lee-Seifert; M Radtke; S J Rustenbach
Journal:  Dermatology       Date:  2009-01-21       Impact factor: 5.366

Review 9.  Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients' experience.

Authors:  Anne Brédart; Alexia Marrel; Linda Abetz-Webb; Kathy Lasch; Catherine Acquadro
Journal:  Health Qual Life Outcomes       Date:  2014-02-05       Impact factor: 3.186

10.  Characterization of different courses of atopic dermatitis in adolescent and adult patients.

Authors:  D Garmhausen; T Hagemann; T Bieber; I Dimitriou; R Fimmers; T Diepgen; N Novak
Journal:  Allergy       Date:  2013-03-01       Impact factor: 13.146

View more
  1 in total

1.  A Framework for Instrument Development of a Choice Experiment: An Application to Type 2 Diabetes.

Authors:  Ellen M Janssen; Jodi B Segal; John F P Bridges
Journal:  Patient       Date:  2016-10       Impact factor: 3.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.